NR1H4 and tuberculosis: These results confirmed that the cholesterol-lowering effect of TB was due to the inhibition of intestinal FXR signaling resulting from the elevation of hepatic CYP7B1 activity, providing a mechanistic link between intestinal FXR signaling and altered hepatic BA synthesis.